OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.

Odobasic, Dragana; Ruth, Amanda J; Oudin, Virginie; Kitching, A Richard; Holdsworth, Stephen R

Odobasic, Dragana; Ruth, Amanda J; Oudin, Virginie; Kitching, A Richard; Holdsworth, Stephen R.

Afiliação

Odobasic D; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia.
Ruth AJ; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia.
Oudin V; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia.
Kitching AR; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, Victoria, Australia.
Holdsworth SR; Department of Pediatric Nephrology, Monash Health, Clayton, Victoria, Australia.

Nephrol Dial Transplant ; 34(3): 429-441, 2019 03 01.

Article em En | MEDLINE | ID: mdl-29939347

Assuntos

Anticorpos Monoclonais/imunologia; Linfócitos T CD4-Positivos/imunologia; Glomerulonefrite/imunologia; Macrófagos/imunologia; Ligante OX40/imunologia; Linfócitos T Reguladores/imunologia; Animais; Glomerulonefrite/metabolismo; Glomerulonefrite/patologia; Interferon gama/metabolismo; Masculino; Camundongos; Camundongos Endogâmicos C57BL; Receptores OX40/metabolismo

Palavras-chave

IFNÎ³; OX40 ligand; crescentic glomerulonephritis; macrophage polarization; regulatory T cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Linfócitos T Reguladores / Ligante OX40 / Glomerulonefrite / Macrófagos / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google